JMP Securities Starts AcelRx Pharmaceuticals (ACRX) at Market Outperform
Tweet
Share
E-mailGet Alerts ACRX Hot Sheet
Price: $0.86 --0%
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
JMP Securities initiates coverage on AcelRx Pharmaceuticals (NASDAQ: ACRX) with a Market Outperform. PT $8.
For more ratings news on AcelRx Pharmaceuticals click here and for the rating history of AcelRx Pharmaceuticals click here.
Shares of AcelRx Pharmaceuticals closed at $3.39 yesterday.
For more ratings news on AcelRx Pharmaceuticals click here and for the rating history of AcelRx Pharmaceuticals click here.
Shares of AcelRx Pharmaceuticals closed at $3.39 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Starts First Advantage (FA) at Outperform, 'Best-in-Class Background Screener'
- Ambit Capital Starts Tata Technologies (TATATECH:IN) at Sell (4)
- BofA Securities Reinstates Gujarat Gas Ltd (GUJGA:IN) at Underperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
